MASONIC MEDICAL RESEARCH LABORATORY

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1947

Legal Domicile

Principal Officer

MARIA KONTARIDIS

Phone

3157352217

Tax Period

2024-01-01 to 2024-12-31

MASONIC MEDICAL RESEARCH LABORATORY, founded in 1947, is a mid-sized nonprofit in the Medical Research sector that reported $10.1M in total revenue in fiscal year 2024. Revenue surged 25% from the prior year, signaling strong growth momentum. Net assets of $35.4M represent 42 months of operating reserves.

Mission

MASONIC MEDICAL RESEARCH LABORATORY, DOING BUSINESS AS MASONIC MEDICAL RESEARCH INSTITUTE, IS A NOT-FOR-PROFIT INSTITUTE DEDICATED TO IMPROVING THE HEALTH AND QUALITY OF LIFE FOR ALL. THE INSTITUTE'S PRIMARY MISSION IS TO CONDUCT HIGH QUALITY BASIC AND CLINICAL RESEARCH AIMED AT GENERATING KNOWLEDGE AND INFORMATION NECESSARY FOR DEVELOPMENT OF THE MEDICAL CURES AND TREATMENTS OF TOMORROW. THE INSTITUTE IS ALSO COMMITTED TO PROVIDING EDUCATION AND TRAINING TO BASIC SCIENTISTS, CLINICAL RESEARCHERS AND STUDENTS WHO WILL PERPETUATE AND EXTEND THE FIGHT AGAINST DISEASE.

Program Service Accomplishments

Program 1

Expenses: $7,407,715

THE MASONIC MEDICAL RESEARCH LABORATORY, DOING BUSINESS AS MASONIC MEDICAL RESEARCH INSTITUTE (MMRI), IS A WORLD RENOWNED MEDICAL RESEARCH CENTER KNOWN FOR ITS SCIENTIFIC ACHIEVEMENTS, ESPECIALLY IN THE FIELD OF EXPERIMENTAL CARDIOLOGY. CURRENT RESEARCH EFFORTS ENCOMPASS ISCHEMIC HEART DISEASE, CARDIAC ARRHYTHMIAS, CARDIOVASCULAR DISEASE AND SUDDEN CARDIAC DEATH. MMRI IS A LEADING CENTER FOR GENETIC SCREENING OF CARDIAC DISEASE AS WELL AS IN THE DEVELOPMENT OF INNOVATIVE AND EFFECTIVE PHARMACOLOGIC TREATMENT FOR ATRIAL FIBRILLATION. THE STEM CELL CENTER IS FOCUSED ON REGENERATING MEDICINE AND THE DEVELOPMENT OF HUMAN MODELS OF DISEASE. OUR SCIENTIFIC FINDINGS ARE PUBLISHED IN THE FINEST MEDICAL JOURNALS IN THE WORLD.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $7,773,270

Program Service Revenue $0

Investment Income $2,284,036

Other Revenue $76,704

TOTAL REVENUE $10,134,010

Expense Breakdown

Grants Paid $0

Salaries & Benefits $6,178,169

Fundraising Expenses $1,295,815

Program Expenses $7,407,715

Other Expenses $4,855,209

TOTAL EXPENSES $11,033,378

Year-over-Year Comparison

	2024	2023	Change
Revenue	$10,134,010	$8,083,309	+0.3%
Expenses	$11,033,378	$10,416,649	+0.1%
Net Income	$-899,368	$-2,333,340	-0.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$851,759

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DAVID F SCHNEEWEISS	CHAIRMAN	5.00	Officer Director	$0	$0	$0
ROBERT A HEWSON DPM	PRESIDENT	5.00	Officer Director	$0	$0	$0
PASQUALE IMBIMBO JR	VICE PRESIDENT	5.00	Officer Director	$0	$0	$0
JAMES D SWAN JR	SECRETARY	5.00	Officer Director	$0	$0	$0
VINCENT CUNZIO CPA	TREASURER	5.00	Officer Director	$0	$0	$0
ALVARO F QUIROGA	PAST PRESIDENT	5.00	Officer Director	$0	$0	$0
MARK D DONNELEY	DIRECTOR	1.00	Director	$0	$0	$0
PETER R GRAY MD PHD FACC	DIRECTOR	1.00	Director	$0	$0	$0
PAUL A GUERRERO CMR	DIRECTOR	1.00	Director	$0	$0	$0
PAUL HUCK ESQ	DIRECTOR	1.00	Director	$0	$0	$0
RICHARD J MILLER JR ESQ	DIRECTOR	1.00	Director	$0	$0	$0
PAUL E MOSSBERG	DIRECTOR	1.00	Director	$0	$0	$0
VIRGILIO S QUIJANO	DIRECTOR	1.00	Director	$0	$0	$0
SHELDON B RICHMAN ESQ	DIRECTOR	1.00	Director	$0	$0	$0
FRANK R WILLIAMS	DIRECTOR	1.00	Director	$0	$0	$0
MARIA KONTARIDIS PHD	EXECUTIVE DIRECTOR	40.00	Officer	$576,104	$83,668	$659,772
STEPHEN IZZO	MAJOR GIFTS OFFICER	40.00	Officer	$150,613	$41,374	$191,987
JASON MCCARTHY	RESEARCH SCIENTIST	40.00	Highest	$182,679	$43,343	$226,022
ZHIQIANG LIN	RESEARCH SCIENTIST	40.00	Highest	$144,978	$38,354	$183,332
CHASE KESSINGER	RESEARCH SCIENTIST	40.00	Highest	$125,240	$37,241	$162,481

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$10,134,010	$11,033,378	$41,674,836	$-899,368
2023	$8,083,309	$10,416,649	$43,915,688	$-2,333,340
2022	$4,154,431	$9,376,509	$51,788,536	$-5,222,078
2021	$10,340,059	$9,361,048	$55,347,194	$979,011
2020	$7,024,223	$9,134,205	$51,996,669	$-2,109,982
2019	$7,857,024	$7,844,864	$52,734,374	$12,160
2018	$8,500,355	$5,010,841	$47,340,752	$3,489,514